Spineway : A Week Dedicated To Medical Excellence With More Than 20 Surgeons Trained


(MENAFN- GlobeNewsWire - Nasdaq) Press release

Ecully, November 14, 2024 – 6 p.m.

Spineway: a week dedicated to medical excellence with more than 20 surgeons trained

The Spineway Group, a , specialist in innovative implants for the treatment of severe spine disorders, organized a week of training dedicated to medical education from November 4 to 8, 2024. Through practical sessions in the operating room and on anatomical specimens in the laboratory, this intensive program trained over 20 international surgeons in the use of the Group's ESP cervical and lumbar prostheses. These events also enabled the Group's distributors to provide ongoing training and support for their users.

The week began with a Costa Rican surgeon being trained in the operating room by Pr. Lazennec (Hôpital de la Pitié-Salpêtrière, AP-HP Paris) on cervical prosthesis (CP-ESP) and lumbar prosthesis (LP-ESP).

This was followed by a training session with two Indonesian surgeons led by Pr. Rousseau (Hôpital Bichat-Beaujon – AP-HP Paris), who focused on the LP-ESP lumbar prosthesis. At the end of the day, Mexican and Costa Rican practitioners had the opportunity to discuss their experiences with disc prostheses with Dr. Thierry Marnay during a round table in Nîmes.

The Mexican practitioners continued their training by participating in several procedures with the LP-ESP lumbar disc prosthesis. These sessions were led by Dr. Guillaume Gras-Combe (CHU de Nîmes-Pôle Neurosciences) and Dr. Jean-Patrick Rakover (Clinique du Pré, Le Mans).

The week ended with a training session on anatomical specimens at IRCAD Strasbourg for all the practitioners trained in the operating room during the week. They were joined by five Spanish and three Portuguese surgeons. Led by the experts Pr. Rousseau, Dr. Gras-Combe, Dr. Javier Giner (Instituto Clavel, Madrid) and Dr. Eduardo Espinosa (Neurocirugía Barcelona), the training included theoretical and practical sessions covering the characteristics, indications and surgical approaches for the placement of ESP disc prostheses.

Spineway's teams, including Yiyi Li (MEA & Asia-Pacific Sales Manager), Lorenzo Tamas (Latin American Sales Manager), Inès Khaoua (Europe Sales Manager), Mélody Ourdouillié (Medical Education Events Manager) and Loïc Aden (ESP Product Manager), were on hand to provide optimal support.

These exchanges between surgeons illustrate Spineway's commitment to supporting health professionals in their training, ensuring mastery of advanced technologies in the field of spinal implants and supporting the development of its international network. Spineway thus confirms its aim of becoming a major player in less invasive spine treatments in Europe, Latin America and Asia.

Next events :

December 5, 2024 – 6 p.m. CET – Webinar – Business update
Register here

January 22, 2025 – Full-year 2024 revenue

SPINEWAY IS ELIGIBLE FOR PEA-SME (EQUITY SAVINGS PLANS FOR SMES)
Find out all about Spineway at

This press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.

Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.
Spineway has an international network of independent distributors and derives more than 70% of its revenue from exports.
ISIN: FR001400BVK2 – ALSPW

Contacts:


SPINEWAY
Shareholder-services line
Available Tuesday through Thursday
+33 (0)806 706 060

AELIUM
Investor relations
Solène Kennis
...



Attachment

  • CPSPW_Formations_Nov_VD_EN

MENAFN14112024004107003653ID1108887244


GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.